Document:

EXHIBIT 10.1

                          FINANCIAL ADVISORY AGREEMENT

      This Agreement is made and entered into as of the 6th day of May, 2005, by
and between Clayton Dunning & Company Inc. ("CDC") and DTOMI, Inc., (the
"Company").

      In consideration of the mutual promises made herein and for other good and
valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto agree as follows:

1.    Purpose: The Company hereby engages CDC for the term specified in
      Paragraph 2 hereof to render financial advisory services to the Company
      upon the terms and conditions set forth herein.

2.    Term: Except as otherwise specified in paragraph 4 hereof, this Agreement
      shall be effective from May 6, 2005 to May 31, 2006.

3.    Duties of CDC: During the term of this Agreement, CDC shall provide the
      Company with such regular and customary financial advisory services as is
      reasonably requested by the Company, provided that CDC shall not be
      required to undertake duties not reasonably within the scope of this
      Agreement. It is understood and acknowledged by the parties that the value
      of CDC's financial advisory services is not readily quantifiable, and that
      although CDC shall be obligated to render the financial advisory services
      contemplated by this Agreement upon the reasonable request of the Company,
      in good faith, CDC shall not be obligated to spend any specific amount of
      time in so doing. CDC's duties may include but will not necessarily be
      limited to, providing recommendations concerning the following matters:

      a.    Rendering financial advisory services with regard to any of the
            following corporate finance matters:

            i.    Changes in the capitalization of the Company;

            ii.   Changes in the Company's corporate structure;

            iii.  Redistribution of shareholdings of the Company's stock;

            iv.   Offerings of securities in public and private transactions;

            v.    Alternative uses of corporate assets;

            vi.   Structure and use of debt;

            vii.  Sales of stock by insiders pursuant to Rule 144 or otherwise;

            viii. Counsel management with respect to listing on a National
                  Exchange; and

            ix.   Strategic planning for the company.

      b.    In addition to the foregoing, CDC agrees to furnish financial
            advisory services to the Company if requested in connection with (i)
            the acquisition of and/or merger with other companies, the sale of
            the Company itself, or any of its assets, subsidiaries or
            affiliates, or similar type of transaction (hereinafter referred to
            as a "Transaction"), and (ii) financings from financial
            institutions, including but not limited to lines of credit,
            performance bonds, letters of credit, loans or other financings
            (hereinafter referred to as a "institutional financing").

4.    Compensation: In consideration for the financial advisory services
      rendered by CDC to the Company pursuant to this Agreement (and in addition
      to the expenses provided for in Paragraph 5 hereof) going forward CDC
      shall be compensated as follows:

      a.    Retainer: The Company agrees to pay CDC 500,000 shares of the
            Company's common stock upon execution of this agreement. The stock
            shall be issued in the name of CDC or as directed by an officer of
            CDC and shall be delivered within seven days of the signing of this
            agreement. The shares shall possess "piggy back" registration
            rights. If registration covering the sale of the stock is not
            effective within one year, the Company agrees to furnish a legal
            opinion covering the sale of the stock pursuant to Rule 144.
<PAGE>

      b.    Cash Compensation Pursuant to Arranging Funding: The Company agrees
            to compensate CDC in an amount of cash equal to 10% of all cash
            received by the Company from the sale of securities or any other
            financing arranged by CDC on behalf of the Company. The compensation
            will be directed to an account of CDC's choosing directly from
            escrow upon closing via federal funds pursuant to written
            instructions provided by CDC to the Company. For the purposes of the
            Agreement, a "Transaction" shall mean any Funding transaction
            originated by CDC, other than in the ordinary course of trade or
            business of the Company, other than a merger or acquisition.

      c.    Equity Compensation Pursuant to Arranging Funding: The Company shall
            deliver to CDC a five (5) year Warrant to purchase that number of
            shares of the common stock of the Company equal to four percent (4%)
            of that number of shares of common stock sold by the Company, at a
            purchase price equal to the transaction price upon the successful
            completion of any financing arranged by CDC. The Warrant shall be
            issued in the name of CDC or as directed by the Chief Executive
            Officer of CDC, and shall be delivered within seven days of the
            closing of the Transaction. The shares underlying the Warrant shall
            possess "piggy back" registration rights to be registered as part of
            the next public registration of the Company's stock. In the event of
            a debt or institutional financing, the Warrant shall have the same
            terms except that the number of shares underlying the Warrant shall
            be equal to 4% of the funds received by the Company divided by the
            average closing bid price of the common stock of the Company for the
            30 days prior to the closing of such debt or institutional
            financing.

      d.    Merger and/or Acquisition. CDC shall be paid a cash fee equal to the
            "Double Lehman" formula based on the total value of any Merger
            and/or Acquisition transaction on which CDC acts as advisor to the
            Company. If the transaction is in total or in part an equity
            transaction, the value of the equity portion shall be based on the
            average trading price for the preceding 30 days before the closing
            of the transaction.

      All fees to be paid pursuant to this Agreement, except as otherwise
      specified, are due and payable to CDC in cash at the closing or closings
      of any transaction specified in Paragraph 4 hereof.

5.    Expenses of CDC: In addition to the fees payable hereunder, and regardless
      of whether any transaction set forth in Paragraph 4 hereof is proposed or
      consummated, the Company shall reimburse CDC for its expenses on a
      non-accountable basis in a cash amount equal to three percent (3%) of all
      cash received by the Company pursuant to this Agreement. Such cash shall
      be payable to CDC in accordance with Section 4(b) hereof. In the event
      that CDC is not involved in a cash financing for the Company, the Company
      shall reimburse CDC for expenses in the form of a promissory note
      convertible into shares of common stock of the Company, with the principal
      amount of such note equal to 3% of the market value of any non-cash
      financing arranged by CDC pursuant to this agreement. The conversion price
      of such promissory note shall be equal to the average closing bid price
      for the shares of common stock of the Company for the 30 days prior to the
      closing of such non-cash financing.

6.    Non-Renewal or Termination. In the event that this Agreement is not
      renewed, or if terminated for any reason, notwithstanding any such
      non-renewal or termination, CDC shall be entitled to full fees and
      expenses as provided under Paragraphs 4 and 5 hereof, for any transaction
      for which discussions were initiated during the term of this Agreement and
      which is consummated within a period of twelve months after non-renewal or
      termination of this Agreement.

7.    Non-Circumvention: Both CDC and the Company agree as follows:

      a.    That each of the named Signatories, separately and individually, and
            their associates, hereby agree that they, or their corporations,
            partnerships, divisions, subsidiaries, employees, agents,
            consultants, principals, parents, or other business relations will
            not make any contract, deal, or agreement to provide debt or equity
            financing with any buyers, sellers, agents, or brokers introduced by
            any of the other Signatories, separately and individually, and their
            associates, without the express consent of the introductory
            Signatory; provided, however, that this Agreement will not apply to
            any entity with whom a Signatory has a pre-existing relationship or
            with whom a Signatory has previously held financial discussions.
            Such previously held discussions shall be listed under a separate
            attachment. This Agreement is also effective for the Signatories'
            heirs, assignees, designees, and introductory agents.
<PAGE>

      b.    By their signature below and execution of this Agreement, each of
            the named Signatories, separately and individually, and their
            associates, confirm that any corporation, partnership, organization,
            firm, company or individual of which the Signee is a part, member,
            principal, agent or otherwise associated with, is bound by this
            Agreement.

      c.    This Agreement is a perpetuating guarantee for one (1) year from the
            date hereof, and is to be applied to any and all transactions
            involving Signatories, and investors introduced by CDC, including
            subsequent, follow-up, repeat, rollover, extended, or re-negotiated
            transactions, as well as to the initial transactions, regardless of
            the success of the project. The Signatories hereby confirm that the
            identities of the banks, lending institutions, corporations,
            partnerships, individuals, trust, lenders, borrowers, buyers,
            sellers, agents and brokers have been and are currently the property
            of the introducing party, and shall remain so for the duration of
            this Agreement.

      d.    The Signatories (and their firms, etc.) agree to keep completely
            confidential, subject to applicable laws or court orders requiring
            disclosure, the names of any banks, lending institutions,
            corporations, partnerships, organizations, individuals, buyers,
            sellers, lenders, borrowers, agents, or brokers introduced by any of
            the other parties to this Agreement during the applicable
            transactions and for the duration of this Agreement. The
            confidentiality shall extend to any names, telephone numbers,
            addresses, fax and telex number, and any other identifying
            information. Such information is considered the property of the
            introductory Signatory, and the parties hereby agree, individually
            and separately, to discuss the same among themselves for the
            determination of what shall be disclosed, and what shall be kept
            confidential.

      e.    It is understood that this Agreement is a reciprocal one by and
            between the Signatories as it pertains to each of their respective
            privileged information and contracts.

      f.    It is understood that a Signatory cannot be considered or adjudged
            to be in violation of this Agreement when the violation is
            involuntary, i.e., due to situations beyond his/her control, such
            as, but not limited to, acts of war, theft, or another's connection
            having prior knowledge or possession of the privileged information
            or contacts without the intervention or assistance of the
            introductory Signatory. Essentially, the spirit of this Agreement is
            one of mutual trust and confidence, and one of reliance on each
            other to do what is fair and equitable.

      g.    If any of the Signatories is an officer of their own corporation,
            this signature represents a corporate guarantee of corporate
            responsibility with respect to this Agreement.

8.    Liability of CDC: The Company acknowledges that all opinions and financial
      advisory services, written or oral, given by CDC to the Company in
      connection with CDC's engagement are intended solely for the benefit and
      use of the Company in considering the transaction to which they relate,
      and the Company agrees that no person or entity other than the Company
      shall be entitled to make use of or rely upon the financial advisory
      services of CDC to be given hereunder, and no such opinion or advice shall
      be used for any other purpose or reproduced, disseminated, quoted or
      referred to at any time, in any manner or for any purpose, nor may the
      company make any public references to CDC, or use CDC's name in any annual
      reports or any other reports or releases of the Company without CDC's
      prior written consent. CDC's maximum liability shall not exceed the cash
      compensation received from the Company.

9.    CDC's Services to Others: The Company acknowledges that CDC or its
      affiliates are in the business of providing a range of financial advisory
      services and financial services to others. Nothing herein contained shall
      be construed to limit or restrict CDC in conducting such business with
      respect to others, or in rendering such financial advisory services and
      financial services to others.

10.   Company Information:
<PAGE>

      a.    The Company acknowledges and agrees that in performing its services
            under this engagement, CDC may rely upon the data, material and
            other information supplied by the Company without independently
            verifying the accuracy, completeness or veracity of same. The
            Company agrees to notify CDC in writing via overnight courier,
            facsimile or e-mail of any material event and/or change within
            twenty-four hours of its occurrence.

      b.    Except as contemplated by the terms hereof or as required by
            applicable law, CDC shall keep confidential all material non-public
            information provided to it by the Company, and shall not disclose
            such information to any third party, other than such of its
            employees and advisors as CDC determines to have a need to know.

11.   Indemnification:

      a.    The Company shall indemnify and hold CDC harmless against any and
            all liabilities, claims, lawsuits, including any and all awards
            and/or judgments to which it may become subject under the Securities
            Act of 1933, as amended (the "1933 Act"), the Securities Exchange
            Act of 1934, as amended (the "Act") or any other federal or state
            statute, at common law or otherwise, insofar as said liabilities,
            claims and lawsuits (including awards and/or judgments) arise out of
            or are in connection with the services rendered by CDC or any
            transactions in connection with this Agreement, except for any
            liabilities, claims and lawsuits (including awards and/or
            judgments), arising out of acts or omissions of CDC. In addition,
            the Company shall also indemnify and hold CDC harmless against any
            and all costs and expenses, including reasonable counsel fees,
            incurred or relating to the foregoing. CDC's maximum liability shall
            not exceed the cash compensation received from the Company.

            CDC contends the subject matter of the Company's indemnification and
            the Company thereupon shall be granted the right to take any and all
            necessary and proper action, at its sold cost and expense, with
            respect to such liability, claim and lawsuit, including the right to
            settle, compromise and dispose of such liability, claim or lawsuit,
            excepting there from any and all proceedings or hearings before any
            regulatory bodies and/or authorities.

            The Company shall give to CDC prompt notice of any such liability,
            claim or lawsuit which the Company contends is the subject matter of
            CDC's indemnification and CDC thereupon shall be granted the right
            to take any and all necessary and proper action, at its sole cost
            and expense, with respect to such liability, claim and lawsuit,
            including the right to settle, compromise or dispose of such
            liability, claim or lawsuit, excepting there from any and all
            proceedings or hearings before any regulatory bodies and/or
            authorities.

      b.    CDC shall indemnify and hold the Company harmless from any claims or
            judgements involving fraud which are the result of any intentional
            act or intentional omission of CDC or its affiliates in connection
            with this Agreement.

      c.    In order to provide for just and equitable contribution under the
            act in any case in which (i) any person entitled to indemnification
            under this Section 9 makes claim for indemnification pursuant hereto
            but it is judicially determined (by the entry or a final judgment or
            decree by a court of competent jurisdiction and the expiration of
            time to appeal or the denial of the last right of appeal) that such
            indemnification may not be enforced in such case notwithstanding the
            fact that this Section 10 provides for indemnification in such case,
            or (ii) contribution under the Act may be required on the part of
            any such person in circumstances for which indemnification is
            provided under this Section 10, then, and in each such case, the
            Company and CDC shall contribute to the aggregate losses, claims,
            damages or liabilities to which they may be subject (after any
            contribution from others) in such proportion taking into
            consideration the relative benefits received by each party from the
            offering covered by the prospectus with respect to any transactions
            in connection with this Agreement (taking into account the position
            of the proceeds of the offering realized by each), the parties'
            relative knowledge and access to information concerning the matter
            with respect to which the claim was assessed, the opportunity to
            correct and prevent any statement or omission and other equitable
            considerations appropriate under the circumstances; provided,
            however, that no person guilty of a fraudulent misrepresentation
            (within the meaning of Section 11(f) of the Act) shall be entitled
            to contribution from any person who was not guilty of such
            fraudulent misrepresentation.
<PAGE>

            Within fifteen (15) days after receipt by any party to this
            Agreement (or its representative) of notice of the commencement of
            any action, suit or proceeding, such party will, if a claim for
            contribution in respect thereof is to be made against another party
            (the "Contributing Party"), notify the Contributing Party of the
            commencement thereof, but the omission so to notify the Contributing
            Party will not relieve it from any liability which it may have to
            any other party other than for contribution hereunder. In case any
            such action, suit or proceeding is brought against any party, and
            such party notifies a Contributing Party or his or its
            representative of the commencement thereof within the aforesaid
            fifteen (15) days, the Contributing Party will be entitled to
            participate therein with the notifying party and any other
            Contributing Party similarly notified. Any such contributing Party
            shall not be liable to any party seeking contribution on account of
            any settlement of any claim, action or proceeding affected by such
            party seeking contribution without the written consent of the
            Contributing Party. The indemnification provisions contained in this
            Section 10 are in addition to any other rights or remedies which
            either party hereto may have with respect to the other or hereunder.

12.   CDC an Independent Contractor: CDC shall perform its services hereunder as
      an independent contractor and not as an employee of the Company or an
      affiliate thereof. It is expressly understood and agreed to by the parties
      hereto that CDC shall have no authority to act for, represent or bind the
      Company or any affiliate thereof in any manner, except as may be agreed to
      expressly by the Company in writing from time to time.

13.   Agreement Renewal and Termination: This Agreement automatically renews
      unless either party terminates prior to sixty days from the termination
      date. Either party at anytime with thirty written notice may terminate
      this Agreement.

14.   Survivability: All paragraphs (Fees, Indemnification, Non-circumvention,
      Liability, etc.) shall survive the termination of this Agreement.

15.   Miscellaneous:

      a.    This Agreement between the Company and CDC constitutes the entire
            agreement and understanding of the parties hereto, and supersedes
            any and all previous agreements and understandings, whether oral or
            written, between the parties with respect to the matters set forth
            herein. The headings and captions in this Agreement are inserted for
            convenience and reference only and shall not be deemed a part hereof
            or used in the construction or interpretation hereof.

      b.    Any notice or communication permitted or required hereunder shall be
            in writing and shall be deemed sufficiently given if hand-delivered
            or sent (i) postage prepaid by registered mail, return receipt
            requested, or (ii) by facsimile, to the respective parties as set
            forth below, or to such other address as either party may notify the
            other in writing.

            If to the Company, to:      John Haddock
                                        President
                                        DTOMI Inc.
                                        950 South Pine Island Road, Suite A150
                                        Plantation, FL 33324

            If to CDC, to:              Robert C. Lau
                                        Chairman and CEO
                                        Clayton Dunning, Inc.
                                        40 Wall Street, 31st Floor
                                        New York, NY 1005

      c.    This Agreement shall be binding upon and inure to the benefit of
            each of the parties hereto and their respective successors, legal
            representatives and assigns.
<PAGE>

      d.    This Agreement may be executed in any number of counterparts, each
            of whom together shall constitute one and the same original
            document.

      e.    No provision of this Agreement may be amended, modified or waived,
            except in a writing signed by all of the parties hereto.

      f.    This Agreement shall be construed in accordance with and governed by
            the laws of the State of New York, without giving effect to conflict
            of law principles. The parties hereby agree that any dispute which
            may arise between them arising out of or in connection with this
            Agreement shall be adjudicated before a court located in
            Connecticut, and they hereby submit to the exclusive jurisdiction of
            the courts of the State of New York with respect to any action or
            legal proceeding commenced by any party, and irrevocably waive any
            objection they now or hereafter may have respecting the venue of any
            such action or proceeding brought in such a court or respecting the
            fact that such court is an inconvenient forum, relating to or
            arising out of this Agreement, and consent to the service of process
            in any such action or legal proceeding by means of registered or
            certified mail, return receipt requested, in care of the address set
            forth in Paragraph 11(b) hereof.

      IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
duly executed, as of the date first above written.

                                       CLAYTON DUNNING & COMPANY, INC.

                                       By:
                                           -------------------------------------
                                           Name: Robert C. Lau
                                           Title: Chairman and CEO

                                       THE COMPANY

                                       By:
                                           -------------------------------------
                                           Name: John Haddock
                                           Title: PresidentEXHIBIT
10.1 

 

Auditor’s
Consent

Statement
by Experts

 

 

 

 

 

 

CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We
consent to the reference to our firm under the caption “Experts” and to the use
of our report dated April 1, 2005, in the Form 20-FR Registration Statement
dated May 25, 2005, Pursuant to Section 12(b) or 12(g) of the Securities and
Exchange Act of 1934, of Poly-Pacific International Inc. for the registration of
9,361,624 shares of its common stock.

	
      Edmonton, Alberta

      May 25, 2005
	 	
      “Collins Barrow Edmonton LLP”

      Signed

      Chartered Accountants

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]